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Any chronic, inﬂammatory, autoimmune disease (e.g. arthritis) asso-
ciated pathogenesis directs uncontrolled accumulation of both solu-
ble forms of collagens in the synovial ﬂuids and M1 macrophages
around inﬂamed tissues. Despite of few studies demonstrating efﬁ-
ciency of Sulforaphane (SFN) in suppressing arthritis associated col-
lagen restricted T cells or ﬁbroblasts, its effects on macrophage
polarity and plasticity are less understood. Recently, we reported
regulation of phenotypic and functional switching by SFN in induced
and spontaneously differentiating human monocytes [1]. Here, ﬂow
cytometry, western blot and ELISA derived data demonstrated that
SFN inhibited in vitro inﬂammatory responses developed by soluble
human collagens (I–IV) induced auto-reactive M1 type monocyte/
macrophage model.
& 2016 Published by Elsevier Inc. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaImmune regulation by phytochemicalis an open access article under the CC BY license
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S. Pal, V.B. Konkimalla / Data in Brief 7 (2016) 1560–1564 1561ype of dataue of the dataImage (western blot), bar-graphs, ﬂow cytometry derived dot plots and
histogramsow data was
acquiredProtein Electrophoresis apparatus (Hoefer, USA), Semi-dry electro-blotter (Bio-
rad, USA), Gel Doc-XRS (Biorad, USA), FACSCaliburTM (BD Biosciences, USA),
Microplate reader (Biorad, USA)ata format Filtered, analyzed
xperimental
factorsHuman monocytic cell line,THP1, Phorbol 12-myristate 13-acetate (PMA),
Lipopolysaccharides (LPS), Interferon gamma (IFNγ), Sulforaphane (SFN),
Human collagens (types I-IV)xperimental
featuresAll analysis was performed using Microsoft Excel or GraphPad software. The
results were expressed as either mean7SD or mean7SEM.ata source
locationNational Institute of Science Education and Research (NISER), Bhubaneswar,
Indiaata accessibility Data are presented in this article.D These in vitro data provide the information on soluble form of human collagen induced functional
M1 polarization in PMA differentiating THP1 monocytes.
 These data indicate the efﬁciency of SFN to bring about phenotypic and functional changes in auto-
reactive M1 cells.
 Data indicates, SFN suppresses auto-reactive M1 macrophages (soluble collagen induced) by
targeting surface CD36, endogenous COX-2, and both inﬂammatory (IL12p70) and anti-
inﬂammatory (IL10) cytokines.1. Data
After comparing a few features of conventional inﬂammatory M1 cells [2–4], the western blot (see
Fig. S1a) and ELISA data (see Fig. S1b) indicate that soluble human collagen-I polarized THP1
monocytes differentiation towards M1 type. Other western blot, FACS proﬁle and quantitative data
obtained from sandwich ELISA have demonstrated that SFN can decrease M1 biomarkers and increase
M2 biomarkers in soluble human collagen induced M1 cells, another sensitive biomarker of chronic
arthritic diseases [5–7] (see Figs. S2–S5).2. Experimental design, materials and methods
2.1. Reagents and antibodies
Buffers and cell culture media such as 10 PBS (#ML023), DMEM (#AL007A), RPMI (#AL162S),
penicillin–streptomycin (Cat no.: A001), Fetal Bovine Serum (#RM9970) were purchased from
HIMEDIA. Collagen type I (C5483), IFNγ (SRP3058) from human origins, lipopolysaccharide from
E. coli 0127:B8 (L3129) as well as chemicals, PMA (P8139) Tris–HCl (#T5941), Trizma base (#T1503),
sodium chloride (#S3014) and methanol (#154903) were procured from Sigma, USA. Several other
chemicals such as L-Sulforaphane [0219378210], DMSO [196055] and protease inhibitor cocktails
[158837] were obtained from MP biomedicals, USA. Collagen type II (CC052), III (CC054), and IV
(CC076) were purchased from Millipore, USA.
For Western blotting, speciﬁc, anti-human primary antibodies raised against COX-2 (#4842), β-
actin (#4970) were obtained from cell signaling technology, USA. Flow cytometry based, ﬂuorophore
conjugated monoclonal antibodies such as mouse anti-human CCR7 (CD197) antibody conjugated to
Scheme 1. Schematic illustration of experimental plans using human monocytic cell line, THP1.
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conjugated to FITC (551135) were obtained from BD biosciences, USA.
2.2. Generation of conventional M1, auto-reactive M1 and immune-suppressive (M2) macrophages
Human monocytic cell line, THP1 was selected for the experiments due to its ability to differ-
entiate into M1 or M2 type macrophages depending on external stimuli [8–10]. About 0.5106 THP1
monocytes were treated with 20 ng/ml PMA alone for initial 6 h and then treated (in presence of
PMA) with LPS (100 ng/ml) and IFNγ (20 ng/ml) together (to derive conventional inﬂammatory M1
cells) or 1 mg/ml soluble collagens I–IV (biomarker of chronic arthritic diseases [11,12]) alone or with
SFN alone for another 24–48 h to polarize THP1 monocytes differentiation. The work plan is described
in Scheme 1.
2.3. Western blotting
Whole cell lysates from individual treatments were prepared in RIPA lysis buffer (150 mM NaCl, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS or sodium dodecyl sulfate, 50 mM Tris buffer pH-8
and 2 protease inhibitor cocktail). Protein concentrations were measured using the Bradford
reagent (Bio-rad #500-0205) and equal amount of total protein per sample was separated by SDS-
PAGE and transferred onto PVDF membranes (IPVH15150, 0.44 mm, Millipore, USA) or (#162-0177,
0.22 mm, Bio-rad, USA) by semi-dry electro-blotting (Bio-rad,USA). After blocking (5% skimmed milk),
proteins detected by incubating the blots with 1:1000 diluted rabbit anti-human monoclonal/poly-
clonal antibodies speciﬁc for the respective protein followed by a goat anti-rabbit antibody con-
jugated to horseradish peroxidase (HRP) (#7074,Cell Signaling, USA). Chemi-luminescence was gen-
erated using the enhanced chemiluminescence ECL kit (#7003, 20 LumiGLOs Reagent and 20
Peroxide, Cell Signaling, USA) following manufacturer's instructions and recorded under Gel Doc-XRS
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loading.
2.4. Cytokine measurement
Using sandwich ELISA, M1 and M2 speciﬁc cytokine production was measured in the supernatants
isolated from each experimental matured macrophages. For this purpose, BD OptEIA™ (BD bios-
ciences) containing sets for both IL-12p70 (M1 type, Cat no. 555183) and IL-10 (M2 type, Cat no.
555157) were used as per the manufacturer instructions to quantify the cytokine levels simulta-
neously. The optical densities at 450 nm were recorded using Biorad plate reader and compared with
a standard curve generated for each cytokine to determine the concentration in each of the experi-
mental samples.
2.5. Surface markers expression
Surface marker expressions on the cells belong to each experimental set up (in presence and
absence of indicated external agents) were analyzed by ﬂow cytometry using FACS CaliburFlow
Cytometer (BD Biosciences). Following treatment, the cells were harvested, washed and a single-cell
suspension were prepared using ice cold PBS. Cells were then washed before and after staining with
500 mL of PBS containing 0.1% BSA and 0.02% sodium azide (FACS buffer). These cells were then
labeled with speciﬁc monoclonal antibodies for 30 min in 50 mL of FACS buffer. About 10,000 events
per sample were acquired and the mean ﬂuorescence intensity (MFI) of cells staining positive for each
surface protein was determined by comparing test samples with unstained, negative control samples.Acknowledgments
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